The Department of Veterans Affairs (VA) Employee Education System (EES), the Pharmacy Benefits Management Services, and the VA Medical Advisory Panel (PBM-MAP), in cooperation with the Southern California Institute for Research and Education (SCIRE), and with acknowledgment from the VHA Oncology Field Advisory Committee, invite you to participate in the Distance Learning Broadcast
Course No. 08.SLC.PBMMM.A.

The purpose of this broadcast is to educate VA health care professionals on the clinical challenges in treating multiple myeloma. Topics, including how to best integrate new drugs into current treatment practices, combination and/or sequence for using them, determining optimal approaches for treating older patients with multiple myeloma, the impact of comorbid conditions, and how to optimize supportive care, will be reviewed.

Rusty Crawford, RPh, BCOP
Clinical Pharmacist for the Division of Hematology/Oncology
Southern Arizona VA Healthcare System
Associate in Pharmacy Practice
Department of Pharmacy Practice
University of Arizona College of Pharmacy
Tucson, Arizona
Adjunct Assistant Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy
Glendale, Arizona

Nikhil C. Munshi, MBBS, MD
Boston VA Health Care System
Associate Director
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

G. David Roodman, MD, PhD
Physician, Division of Hematology/Oncology
Pittsburgh VA Health Care System
Director, Multiple Myeloma Center
University of Pittsburgh Cancer Institute (UPCI)
Professor of Medicine
Division of Hematology/Oncology
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Satellite Broadcast
Tuesday, July 15, 2008, at 1:00 PM ET Channel 2

The broadcast will be followed by VA Nationwide Teleconference System (VANTS) conference calls on Tuesday, July 15, 2008, at 2:00 PM ET and then on Tuesday, August 26, 2008, at 2:00 PM ET that will provide an opportunity for participants and faculty to discuss issues covered in the broadcast.

Dial-in Number: 1-800-767-1750
Access Code: 86360#

View Evolving Care for Multiple Myeloma at your local satellite site or via recording at a location determined by your facility. Location for viewing a recording is at viewer discretion and as facility resources permit.

The broadcast can also be viewed on your desktop at the designated dates and times listed on Content Distribution Network (CDN) at http://vaww.vakncdn.lrn.va.gov/Default.asp.

For CEUs, a Scantron^® program evaluation, faculty evaluation, and post test (with a score of 70% or better) must be completed and mailed. For more program information/brochure, slides of presentation, Scantron directions, and accreditation information, please access the program information at the VA Learning Catalog at http://vaww.sites.lrn.va.gov/vacatalog/cu_detail.asp?id=24310.

Note: Continuing education credit for these scheduled satellite broadcasts will not be offered by EES after September 30, 2008.

Information on participation may be obtained from Dr. Karen McCoy, Project Manager, EES, Salt Lake City Employee Education Resource Center, phone 801-944-1265, e-mail Karen.McCoy@va.gov or Richard Brockmyer, Program Support Assistant, EES, Salt Lake City Employee Education Resource Center, phone 801-924-6841, e-mail Richard.Brockmyer@va.gov.

For more information about the products and services provided by the EES, visit our Web site at http://vaww.ees.lrn.va.gov/.

Please refer to http://vaww.pbm.va.gov/PBM/dislearning.htm or www.pbm.va.gov/DistanceLearning-Broadcast.aspx for topics and schedules of future broadcasts.

This program is designed for physicians, nurses, and clinical pharmacy staff involved with diagnosing and treating patients with multiple myeloma.

Accreditation Council for Continuing Medical Education (ACCME)
The VA EES is accredited by the ACCME to provide continuing medical education (CME) for physicians.

The VA EES designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity is certified to provide continuing education credit to practitioners seeking Category 1 AMA PRA credit when viewed live.

American Nurses Credentialing Center (ANCC)
The VA EES is accredited as a provider of continuing nursing education by the ANCC Commission on Accreditation.

The VA EES designates this educational activity for 1.0 contact hour in continuing nursing education. This activity is certified to provide credit to practitioners seeking ANCC credit when viewed live or scheduled rebroadcasts or a recording.


NOTE: The California (CA) Board of Registered Nursing (BRN) will not accept ANCC credit toward the renewal of CA licensure, unless the CA licensed nurse-participants are physically outside of the state of CA when they commence and complete ANCC-accredited educational activities.

California Board of Registered Nursing (CA BRN)
The VA EES is accredited as a provider of continuing education in nursing by the CA BRN.

This CE activity has been presented by the VA EES for 1.0 contact hour. Provider approved by the CA BRN: Provider Number CEP 4714.

Accreditation Council for Pharmacy Education (ACPE)
The VA EES is accredited by the ACPE as a provider of continuing pharmacy education.
Program #610-000-08-041-H01-P is accredited for 1.0 contact hour.
The EES maintains responsibility for the program. A statement of credit will be awarded to participants and accreditation records will be on file at the EES. In order to receive continuing pharmacy education credit, participants must attend 100% of the program and complete an evaluation form. Statements of credit will be mailed to participants within 6 weeks of the educational activity’s conclusion.

Continuing education credit will not be offered by EES after Tuesday, September 30, 2008, for viewing Evolving Care for Multiple Myeloma.

This activity is certified to provide credit to practitioners seeking approval/accreditation when viewed live or scheduled rebroadcast. Other than as specified above, credit is not available for participants viewing this activity on demand from a recording.

After October 1, 2008, on-demand viewing of the program will be available on Content Distribution Network (CDN) at http://vaww.vakncdn.lrn.va.gov/Default.asp. Only ACPE credits will be offered when program is viewed via CDN following October 1, 2008.

It is the participant's responsibility to ensure that this training is documented in the appropriate location according to his/her locally prescribed process.

The VA EES must insure balance, independence, objectivity, and scientific rigor in all its individually sponsored or jointly EES-sponsored educational activities. All prospective faculty and planning committee members participating in an EES activity must disclose any relevant financial interest or other relationship with: (a) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation, and (b) any commercial supporters of the activity. Relevant financial interest or other relationship includes, but is not limited to, such things as personal receipt of grants or research support, employee or consultant status, stockholder, member of speakers’ bureau, within the prior 12 months. EES is responsible for collecting such information from prospective planners and faculty, evaluating the disclosed information to determine if a conflict of interest is present and, if a conflict of interest is present, to resolve such conflict. Information regarding such disclosures and the resolution of the conflicts for planners and faculty shall be provided to activity participants. When an unlabeled use of a commercial product or an investigational use not yet approved by the FDA for any purpose is discussed during an educational activity, EES shall require the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

Each faculty and planning committee member (author, facilitator, moderator) reported having no relevant* financial relationships with any commercial interest. This activity includes no discussion of uses of FDA-regulated drugs or medical devices that are experimental or off-label.

*The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.